New diabetes clinical trial: Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes - A Randomized Trial

Published on: June 17, 2025 at 11:00PM
Conditions: Type 2 Diabetes Mellitus (T2DM); Chronic Kidney Disease Due to Type 2 Diabetes Mellitus; Cardiovascular Diseases
Interventions: Drug: Finerenone (BAY 94-8862); Drug: Placebo
Sponsors: University of Aarhus; Aarhus University Hospital
Recruiting
https://ift.tt/4gUGDM6